DAVID LOUIS PORTER
Medical Practice in Delaware
License number
Pennsylvania MD057776L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Delaware
Media, PA 19064
Media, PA 19064
Personal information
See more information about DAVID LOUIS PORTER at radaris.comName
Address
Phone
460 Mower Rd, Chambersburg, PA 17202
424 E Maiden St, Washington, PA 15301
427 Roslyn Ave, Glenside, PA 19038
Professional information
Compositions For Treatment Of Cancer
US Patent:
2013028, Oct 31, 2013
Filed:
Jul 10, 2013
Appl. No.:
13/938923
Inventors:
Bruce L. Levine - Cherry Hill NJ, US
David L. Porter - Springfield PA, US
Michael D. Kalos - Philadelphia PA, US
Michael C. Milone - Cherry Hill NJ, US
David L. Porter - Springfield PA, US
Michael D. Kalos - Philadelphia PA, US
Michael C. Milone - Cherry Hill NJ, US
International Classification:
A61K 35/14
US Classification:
4353723
Abstract:
The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.
Use Of Chimeric Antigen Receptor-Modified T-Cells To Treat Cancer
US Patent:
2013028, Oct 31, 2013
Filed:
Dec 9, 2011
Appl. No.:
13/992622
Inventors:
Carl H. June - Merion Station PA, US
Bruce L. Levine - Cherry Hill NJ, US
David L. Porter - Springfield PA, US
Michael D. Kalos - Philadelphia PA, US
Michael C. Milone - Cherry Hill NJ, US
Bruce L. Levine - Cherry Hill NJ, US
David L. Porter - Springfield PA, US
Michael D. Kalos - Philadelphia PA, US
Michael C. Milone - Cherry Hill NJ, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61K 35/14
US Classification:
424 9321, 536 234, 5303873, 435328, 4353201
Abstract:
The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.
Methods For Treatment Of Cancer
US Patent:
2013030, Nov 21, 2013
Filed:
Jul 10, 2013
Appl. No.:
13/938947
Inventors:
Bruce L. Levine - Cherry Hill NJ, US
David L. Porter - Springfield PA, US
Michael D. Kalos - Philadelphia PA, US
Michael C. Milone - Cherry Hill NJ, US
David L. Porter - Springfield PA, US
Michael D. Kalos - Philadelphia PA, US
Michael C. Milone - Cherry Hill NJ, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61K 35/14
US Classification:
4241841
Abstract:
The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.